ATE274900T1 - Stabilgelmischung in form einer mischung eines öligen gels und eines wässrigen gels - Google Patents

Stabilgelmischung in form einer mischung eines öligen gels und eines wässrigen gels

Info

Publication number
ATE274900T1
ATE274900T1 AT99922436T AT99922436T ATE274900T1 AT E274900 T1 ATE274900 T1 AT E274900T1 AT 99922436 T AT99922436 T AT 99922436T AT 99922436 T AT99922436 T AT 99922436T AT E274900 T1 ATE274900 T1 AT E274900T1
Authority
AT
Austria
Prior art keywords
gel
mixture
stable
watery
oily
Prior art date
Application number
AT99922436T
Other languages
English (en)
Inventor
Jean-Marc Aiache
Pascale Gauthier
Original Assignee
Jean-Marc Aiache
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26234356&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE274900(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR9806958A external-priority patent/FR2779438B1/fr
Application filed by Jean-Marc Aiache filed Critical Jean-Marc Aiache
Application granted granted Critical
Publication of ATE274900T1 publication Critical patent/ATE274900T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/042Gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/731Cellulose; Quaternized cellulose derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08Cellulose derivatives
    • C08L1/26Cellulose ethers
    • C08L1/28Alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/48Thickener, Thickening system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT99922436T 1998-06-03 1999-06-03 Stabilgelmischung in form einer mischung eines öligen gels und eines wässrigen gels ATE274900T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9806958A FR2779438B1 (fr) 1998-06-03 1998-06-03 Gel stable, son procede de preparation, et compositions pharmaceutiques le comprenant
US09/204,089 US6187323B1 (en) 1998-06-03 1998-12-03 Stable gel mixture in the form of a mixture of oleogel and aqueous gel, process for its preparation, pharmaceutical and cosmetic compositions comprising it, and use of the pharmaceutical compositions
PCT/IB1999/001068 WO1999062497A1 (en) 1998-06-03 1999-06-03 Stable gel mixture in the form of a mixture of oleogel and aqueous gel

Publications (1)

Publication Number Publication Date
ATE274900T1 true ATE274900T1 (de) 2004-09-15

Family

ID=26234356

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99922436T ATE274900T1 (de) 1998-06-03 1999-06-03 Stabilgelmischung in form einer mischung eines öligen gels und eines wässrigen gels

Country Status (6)

Country Link
EP (1) EP1083880B1 (de)
AT (1) ATE274900T1 (de)
AU (1) AU3951399A (de)
DE (1) DE69919863T8 (de)
ES (1) ES2228044T3 (de)
WO (1) WO1999062497A1 (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002950506A0 (en) * 2002-07-31 2002-09-12 Soltec Research Pty Ltd Percutaneous delivery system
GB0524961D0 (en) * 2005-12-07 2006-01-18 Pharmakodex Ltd Transdermal administration of active agents for systemic effect
MA29127B1 (fr) * 2006-06-30 2008-01-02 Yahya Bensouda Formulation d'une emulsion lipidique pour nutrition parenterale a base d'huile d'argane
GB2445539A (en) * 2006-12-29 2008-07-16 Ardana Bioscience Ltd Bigel composition
CN102548425B (zh) 2009-06-12 2017-09-29 马斯公司 含有乙基纤维素的巧克力组合物
GB2485421B (en) 2010-11-15 2016-05-25 Mars Inc Dough products exhibiting reduced oil migration
CA2813088C (en) 2010-12-01 2019-05-14 Omnis Biotechnology Inc. Thixotropic compositions
RS62297B1 (sr) 2011-11-23 2021-09-30 Therapeuticsmd Inc Prirodne kombinovane hormonske supstitucione formulacije i terapije
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
MX367984B (es) 2012-09-28 2019-09-13 Mars Inc Chocolate resistente al calor.
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
FR3002444B1 (fr) * 2013-02-25 2015-03-13 Oreal Composition cosmetique de type gel
FR3002449B1 (fr) 2013-02-25 2015-04-03 Oreal Composition cosmetique de type gel
FR3002448B1 (fr) * 2013-02-25 2015-04-03 Oreal Composition cosmetique de type gel
FR3004343B1 (fr) * 2013-04-12 2015-06-19 Oreal Composition cosmetique de type gel
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
FR3021533B1 (fr) * 2014-05-28 2017-09-15 Oreal Composition cosmetique de type gel
EP3174542A4 (de) * 2014-07-29 2018-01-03 TherapeuticsMD, Inc. Transdermale creme
FR3025100B1 (fr) 2014-08-28 2016-12-09 Oreal Composition cosmetique de type gel a tenue amelioree
EP3185843B2 (de) 2014-08-28 2025-07-02 L'oreal Gelzusammensetzung und gel mit einem uv-filter
FR3025097B1 (fr) 2014-08-28 2016-12-23 Oreal Gel/gel comprenant au moins deux charges a effet flouteur
FR3025096B1 (fr) 2014-08-28 2016-12-23 Oreal Composition gel/gel contenant un actif anti-transpirant
FR3025098B1 (fr) 2014-08-28 2018-03-09 Oreal Composition cosmetique de type gel facilement demaquillable
FR3025099B1 (fr) 2014-08-28 2016-12-16 Oreal Composition cosmetique de type gel a tenue amelioree et non collante
FR3028753B1 (fr) * 2014-11-24 2018-01-05 L'oreal Gel aqueux ou hydroalcoolique de phyllosilicates synthetiques a titre d'agent viscosant, matifiant et/ou homogeneisant d'application
FR3030261B1 (fr) 2014-12-18 2017-01-13 Oreal Composition comprenant des particules de polymere stabilise et un polymere filmogene hydrophobe
DE102015207624A1 (de) 2015-04-27 2016-10-27 Beiersdorf Ag Hautpflegezubereitung
DE102015207621A1 (de) 2015-04-27 2016-10-27 Beiersdorf Ag Hautreinigungszubereitung
WO2017102359A1 (en) 2015-12-17 2017-06-22 L'oreal Composition of gel/gel type based on hydrophobic coated pigments and a liquid fatty acid and/or a glycol compound
ES2949053T3 (es) * 2016-01-07 2023-09-25 Viramal Ltd Composiciones de gel para administración transdérmica para maximizar las concentraciones de fármaco en el estrato córneo y suero, y métodos de uso de las mismas
FR3067934B1 (fr) 2017-06-27 2019-08-09 L'oreal Composition gelifiee comprenant une dispersion d'agregats solides.
FR3067937B1 (fr) 2017-06-27 2019-12-20 L'oreal Composition gel-gel comprenant une cire a l'etat cristallin.
KR102692643B1 (ko) * 2017-11-10 2024-08-06 (주)아모레퍼시픽 바이겔 타입의 화장료 조성물
FR3075053B1 (fr) 2017-12-15 2020-07-10 L'oreal Composition de type gel/gel a base de pigments, d’au moins un dihydroxyalcane lineaire sature en c3-c8, d’acide salicylique sous forme libre
FR3076218B1 (fr) 2017-12-28 2019-12-27 L'oreal Composition gelifiee comprenant une microdispersion aqueuse de cire(s)
EP3870150A1 (de) 2018-10-26 2021-09-01 Viramal Limited Mukoadhäsive gelzusammensetzung
ES2948955T3 (es) 2018-11-30 2023-09-22 Viramal Ltd Un método de preparación de un agente gelificante, el agente gelificante obtenido de este modo y el uso de dicho agente gelificante
FR3090327B1 (fr) 2018-12-20 2020-12-25 Oreal Composition gélifiée comprenant deux gélifiants hydrophiles et des agrégats solides
FR3090325B1 (fr) 2018-12-21 2021-01-01 Oreal Composition du type gel/gel comprenant des particules de nitrure de bore et au moins un pigment encapsule
DE102019119888A1 (de) * 2019-07-23 2021-01-28 Fachhochschule Bielefeld Neue Formulierung auf Basis eines Oleogels insbesondere zur Freisetzung von volatilen Komponenten und Verfahren zu dessen Herstellung
US20220354756A1 (en) * 2019-07-24 2022-11-10 Shiseido Company, Ltd. A water-in-oil emulsion with emollient and methods of using the same
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
EP3922235A1 (de) 2020-06-11 2021-12-15 Viramal Limited Hydroalkoholisches gel und verfahren zu seiner herstellung
US20240373870A1 (en) * 2021-07-08 2024-11-14 Minutri Inc. Gel compositions with high thermal stability and methods of making the same
CN114191381B (zh) * 2021-11-29 2023-10-24 华南农业大学 一种温敏型模拟塑性脂肪、口腔质构及消化行为可控的双凝胶及其制备和应用
CN116271198B (zh) * 2021-12-21 2025-12-12 中国科学院理化技术研究所 一种自导出敷料及其制备方法
CN115429703B (zh) * 2022-10-24 2023-09-22 中国热带农业科学院农产品加工研究所 双凝胶组合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2635463A1 (fr) * 1988-08-19 1990-02-23 Veprol Composition pharmaceutique comportant un principe actif peu soluble dans l'eau et au moins un glyceride gelifie par au moins un polymere cellulosique
GB9207988D0 (en) * 1992-04-10 1992-05-27 Smithkline Beecham Plc Topical composition
KR970064620A (ko) * 1996-03-05 1997-10-13 임성기 사이클로스포린-함유 외용약제 조성물

Also Published As

Publication number Publication date
WO1999062497A1 (en) 1999-12-09
DE69919863T2 (de) 2005-09-01
DE69919863D1 (de) 2004-10-07
EP1083880B1 (de) 2004-09-01
AU3951399A (en) 1999-12-20
DE69919863T8 (de) 2005-12-15
EP1083880A1 (de) 2001-03-21
ES2228044T3 (es) 2005-04-01

Similar Documents

Publication Publication Date Title
DE69919863D1 (de) Stabilgelmischung in form einer mischung eines öligen gels und eines wässrigen gels
NO992980D0 (no) Nitroimidazol gelblanding
ATE269113T1 (de) Sprühfähige wundversorgungszusammensetzung
DE69828958D1 (de) Arzneiformulierungen zur hormonersatztherapie zur topischen anwendung auf der haut
ES2151968T3 (es) Composiciones hemorroidales y metodo de utilizacion.
DK1299108T3 (da) Parasiticidt præparat samt fremgangsmåde til fremstilling af dette præparat
ATE421318T1 (de) Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben
BR0314354A (pt) Formação para gentes lipofìlicos
ATE314092T1 (de) Biologische kleber und verfahren zur topischen verabreichung von wirkstoffen
DE69922152D1 (de) Stabile ascorbinsäure enthaltende zubereitung zur topischen anwendung
ATE324907T1 (de) Verbindung und arzneizusammensetzung zur verabreichung von wirkstoffen
WO2002019981A3 (en) Cosmetic and pharmaceutical composition comprising chelating/sequestering agents and their cosmetic and dermatological use
BR9704554B1 (pt) utilizaÇço de lipÍdios complexos como adiÇÕes de estabilizaÇço para composiÇÕes farmacÊuticas de misturas de enzimas de digestço, composiÇÕes farmacÊuticas soléveis em Água e kit para preparaÇço de soluÇÕes aquosas.
ATE253820T1 (de) Wirkstoffhaltige komposition sowie deren herstellung und verwendung
MXPA01011941A (es) Humectante cosmetico no pegajoso para la piel y el cabello.
RU95106487A (ru) Применение гуаровой смолы, косметический состав и способ придания формы кератиновым волокнам
ES2137044T3 (es) Utilizacion de derivados de oxazolidinona como agentes antipenetrantes en una composicion cosmetica y/o dermatologica.
BR9915955A (pt) Composição cosmética para cuidado com a pele, processo cosmético para tratar uma pele envelhecida e uso de 4- cromanona
ES2178405T3 (es) Uso de selegilina o de desmetilselegilina para tratar heridas, quemaduras y lesiones cutaneas.
CA2494473A1 (en) Stabilized protein compositions for topical administration and methods of making same
ES2102284T5 (es) Composicion cosmetica que comprende una asociacion de ceramidas y su utilizacion.
ES2172095T3 (es) Utilizacion de sulfitos y metabisulfitos, para la fabricacion de composiciones cosmeticas o farmaceuticas, particularmente en dermatologia, con efecto inhibidor de la melanogenesis o con actividad despigmentante.
BR0009194A (pt) Composição do resorcinol
ATE131031T1 (de) Zubereitung zur topischen anwendung.
ES2161913T3 (es) Complejos cationicos trinucleares de platino que tienen una actividad antitumoral y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1083880

Country of ref document: EP